Adam Maeder
Stock Analyst at Piper Sandler
(3.36)
# 2,150
Out of 5,040 analysts
95
Total ratings
43.75%
Success rate
6.32%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $551.30 | +10.65% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $5.98 | +17.06% | 8 | Aug 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $233 → $150 | $80.17 | +87.10% | 15 | Aug 5, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $265.26 | +1.79% | 4 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $83 → $90 | $76.53 | +17.60% | 16 | Jul 25, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $8.43 | +18.62% | 2 | Jul 9, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $5.21 | -23.22% | 1 | Jun 18, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.25 | +77.78% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $14.95 | -6.35% | 3 | May 6, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $126.34 | +14.77% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $18.64 | +12.66% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $2.96 | +170.27% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $5.67 | +252.73% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $3.10 | +61.29% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $1.32 | +1,263.64% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $54.44 | +81.85% | 3 | May 5, 2022 |
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $551.30
Upside: +10.65%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $5.98
Upside: +17.06%
Inspire Medical Systems
Aug 5, 2025
Maintains: Overweight
Price Target: $233 → $150
Current: $80.17
Upside: +87.10%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $265.26
Upside: +1.79%
Edwards Lifesciences
Jul 25, 2025
Maintains: Overweight
Price Target: $83 → $90
Current: $76.53
Upside: +17.60%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $8.43
Upside: +18.62%
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $5.21
Upside: -23.22%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.25
Upside: +77.78%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $14.95
Upside: -6.35%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $126.34
Upside: +14.77%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $18.64
Upside: +12.66%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $2.96
Upside: +170.27%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $5.67
Upside: +252.73%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $3.10
Upside: +61.29%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $1.32
Upside: +1,263.64%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $54.44
Upside: +81.85%